Skip to content

Magnesium and sleep quality: grade C

Limited evidence. Direction: Benefit.

Evidence maturity: EmergingSubjective outcome onlyShort-term only

Why this grade

Rubric condition met: C: small or short trials with inconsistent results; a university-funded RCT (n = 155) showed a small, borderline effect, and a 2026 systematic review of 12 RCTs rated certainty low to very low

The largest university-funded trial (magnesium bisglycinate, 155 adults reporting poor sleep; one author runs a contract research organization funded by nutraceutical companies) found a greater fall in Insomnia Severity Index score than placebo at week 4, with a small effect (d = 0.2, p = 0.049). A 2026 systematic review of 12 RCTs found inconsistent results across subjective and objective measures and rated certainty low to very low, concluding that current evidence does not support oral magnesium as a routine approach for people with insomnia. Two magnesium L-threonate trials were funded by ingredient suppliers, and the larger one found no ring-measured sleep differences. One large RCT could support a B, but the conflicting syntheses and mostly subjective outcomes keep this at C.

How sure are we?

Evidence maturity: Emerging Two or more RCTs in adults reporting poor sleep, but no preregistered independent RCT positive on its primary could be confirmed; certainty low to very low.

Tested as: Magnesium (mostly bisglycinate and other salts)

Who paid for the studies
Mixed
Risk of bias
Some concerns. The 2026 review that rates certainty low to very low is led by an author of the Threotech-funded trial and co-author of the bisglycinate trial.
Trial registry check
Not checked yet
Outcome measured
A test score, rating scale or performance measure
Who was studied
Matched
Material tested
Largest trial: magnesium bisglycinate
Doses used in studies
250 mg elemental magnesium a day (bisglycinate) in the largest trial
  • Could rise: Would move to B with an independent preregistered RCT in 100 or more adults with poor sleep, positive on a prespecified sleep primary.
  • Could fall: Would move to N with two adequately sized independent RCTs null on the primary.

Science is provisional. This grade reflects the evidence we found as of . Next review: .

Maturity sits beside each grade. The grade says what the evidence shows; maturity says how much of it there is and how well it is confirmed.

Established
many trials from several independent teams, including at least one registered in advance
Emerging
two or more trials, or one large registered trial, not yet independently confirmed
Early signal
one trial, small pilots, or results only on secondary outcomes
Mechanistic only
lab, animal or biomarker data, or uncontrolled reports; no controlled human results
Traditional use only
a traditional-use monograph and nothing else

How we grade evidence

Studies this grade rests on

EffectMixedNo effectSize shows participants (n)202020252030Meta-analysisSystematic reviewRCTSchuster 2025, 2025: RCT, n = 155, result not recordedMah 2021, 2021: meta-analysis, n = 151, result not recordedLopresti 2025, 2025: RCT, n = 100, result not recordedHausenblas 2024, 2024: RCT, n = 80, result not recordedLopresti 2026, 2026: systematic review, n not recorded, result not recorded
each study this grade rests on, by publication year and design. Solid: effect versus the comparator; half-filled: mixed; hollow: no effect; dashed: result not recorded yet. Larger marks had more participants.
Show the numbers
StudyYearDesignParticipantsResult
Mah 20212021meta-analysis151result not recorded
Hausenblas 20242024RCT80result not recorded
Lopresti 20252025RCT100result not recorded
Schuster 20252025RCT155result not recorded
Lopresti 20262026systematic reviewnot recordedresult not recorded

The effects of magnesium L-threonate (Magtein(®)) on cognitive performance and sleep quality in adults: a randomised, double-blind, placebo-controlled trial.

Lopresti AL, Smith SJ. The effects of magnesium L-threonate (Magtein(®)) on cognitive performance and sleep quality in adults: a randomised, double-blind, placebo-controlled trial Front Nutr, 2025. PMID 41601871

Result not recorded
Design
Randomized, double-blind, placebo-controlled, parallel-group trial, 6 weeks
Sample
n = 100
Population
Adults aged 18-45 with self-reported dissatisfied sleep
Funding
Threotech Inc. (COI statement)

Magnesium-L-threonate improves sleep quality and daytime functioning in adults with self-reported sleep problems: A randomized controlled trial.

Hausenblas HA, Lynch T, Hooper S. Magnesium-L-threonate improves sleep quality and daytime functioning in adults with self-reported sleep problems: A randomized controlled trial Sleep Med X, 2024. PMID 39252819

Result not recorded
Design
Randomized, double-blind, placebo-controlled, parallel-arm trial, 21 days
Sample
n = 80
Population
Adults aged 35-55 with self-reported sleep problems
Funding
AIDP Inc. (full text funding statement and 2025 corrigendum)

Magnesium Bisglycinate Supplementation in Healthy Adults Reporting Poor Sleep: A Randomized, Placebo-Controlled Trial.

Schuster J, Cycelskij I, Lopresti A. Magnesium Bisglycinate Supplementation in Healthy Adults Reporting Poor Sleep: A Randomized, Placebo-Controlled Trial Nat Sci Sleep, 2025. PMID 40918053

Result not recorded
Design
Randomized, double-blind, placebo-controlled trial (PubMed publication type 'Case Reports' is a database tagging error)
Sample
n = 155
Population
Healthy adults aged 18-65 reporting poor sleep quality
Funding
Institute of Food and One Health, Leibniz University Hannover (full text)

Magnesium Supplementation for Sleep in Adults: A Systematic Review of Randomized Controlled Trials.

Lopresti AL, Smith SJ, Drummond PD. Magnesium Supplementation for Sleep in Adults: A Systematic Review of Randomized Controlled Trials J Diet Suppl, 2026. PMID 42661485

Result not recorded
Design
Systematic review of randomized controlled trials (12 in the main sleep synthesis), narrative synthesis with GRADE
Population
Adults (healthy and clinical samples)
Funding
not stated

Oral magnesium supplementation for insomnia in older adults: a Systematic Review & Meta-Analysis.

Mah J, Pitre T. Oral magnesium supplementation for insomnia in older adults: a Systematic Review & Meta-Analysis BMC Complement Med Ther, 2021. PMID 33865376

Result not recorded
Design
Systematic review and meta-analysis of 3 randomized placebo-controlled trials
Sample
n = 151
Population
Older adults with insomnia (clinical population; mean ages 59-65)
Funding
No specific grant (full text funding statement)

Search and history

Search (): magnesium[ti] AND sleep[tiab] AND (meta-analysis[pt] OR systematic review[pt])

  • Graded C (awaiting approval)
  • C to C (awaiting approval) (maturity: emerging): Maturity, bias summary and re-check date added
  • C to C (approved) (maturity: emerging): Editor sign-off November 16, 2026: grade matches the editor-approved final page